MVIS US Listed Biotech 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that generate at least 50% of their revenues from biotechnology. The pure-play index contains only companies which are engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. The MVIS US Listed Biotech 25 Index (MVBBH) has been licensed to underlie financial products with currently USD 367.5 million in assets under management.

Components

The MVIS US Listed Biotech 25 Index counts currently 24 components. The full list of the components with the respective weights is available below.

Items 1-24 of total 24
ComponentCountryWeight
AMGEN INCUS11.81%
GILEAD SCIENCES INCUS7.13%
VERTEX PHARMACEUTICALS INCUS5.99%
BIOGEN INCUS5.84%
REGENERON PHARMACEUTICALSUS5.59%
ALLERGAN PLCIE5.35%
ILLUMINA INCUS5.22%
INCYTE CORPUS5.13%
IQVIA HOLDINGS INCUS4.51%
ALEXION PHARMACEUTICALS INCUS4.27%
BIOMARIN PHARMACEUTICAL INCUS4.03%
QIAGEN NVNL3.96%
ALNYLAM PHARMACEUTICALS INCUS3.77%
EXACT SCIENCES CORPUS3.69%
BEIGENE LTD-ADRKY3.63%
NEUROCRINE BIOSCIENCES INCUS3.36%
CHARLES RIVER LABORATORIESUS3.13%
SAREPTA THERAPEUTICS INCUS2.94%
GRIFOLS SA-ADRES2.73%
SEATTLE GENETICS INCUS2.49%
IONIS PHARMACEUTICALS INCUS1.85%
GUARDANT HEALTH INCUS1.77%
UNITED THERAPEUTICS CORPUS1.29%
BLUEBIRD BIO INCUS0.53%
Items 1-24 of total 24
Up